Approximately 70% of breast tumors containing germline BRCA1 mutations are diagnosed as triple-negative breast cancer (TNBC), a highly aggressive subtype of breast cancer associated with poor outcomes due to limited treatment options [2, 4]. Here, BRCA1 is linked to triple-negative breast carcinoma.